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SCIENTIFIC OPINION 
Scientific Opinion on the reconsideration of the ADI and a refined exposure 
assessment of β-apo-8′-carotenal (E 160e)
1 
EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS)
2,3 
European Food Safety Authority (EFSA), Parma, Italy 
This scientific opinion, published on 24 March 2014, replaces the earlier version published on 22 January 2014. 
ABSTRACT 
The Panel on Food Additives and Nutrient Sources added to Food (ANS) has previously provided a scientific 
opinion re-evaluating the safety of β-apo-8′-carotenal (E 160e) as a food additive in the EU and establishing an 
acceptable daily intake (ADI) of 0.05 mg/kg body  weight (bw)/day (EFSA  ANS Panel, 2012). Following a 
request by the European Commission, the ANS Panel was asked to consider newly submitted information on the 
interpretation of the 13-week study in rats used as a basis to establish the ADI, to clarify its impact on that ADI 
and to carry out the refined exposure assessment of  β-apo-8′-carotenal. The  new  information comprised an 
evaluation of all of the original kidney section slides from the 13-week toxicological study under improved 
visualisation conditions. The ANS Panel has considered that the supplementary information provided by the 
Commission  and  the  present  toxicological  database  on  β-apo-8′-carotenal  provides  a  basis  to  revise  the 
established ADI and concluded that, based on the NOAEL of 30 mg/kg bw/day from the 13-week study in rats 
and an uncertainty factor of 100, a new ADI for β-apo-8′-carotenal of 0.3 mg/kg bw/day can be established. The 
Panel concluded that using data provided by the food industry, which are based only on a limited number of 
regulated categories, the reported uses and use levels of β-apo-8‟-carotenal (E 160e) would not be of safety 
concern. 
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SUMMARY 
Following a request from the European Commission (EC) to the European Food Safety Authority 
(EFSA), the EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS) delivered a 
scientific opinion reevaluating the safety of β-apo-8′-carotenal (E 160e) when used as a food colour 
(EFSA  ANS  Panel, 2012).  In  this  re-evaluation,  the  ANS  Panel  used  a 13-week  study  in  rats  to 
establish an acceptable daily intake (ADI) of 0.05 mg/kg body weight (bw)/day for β-apo-8′-carotenal 
(E 160e). 
After  the  publication  of  the  EFSA  opinion,  the  European  Commission  received  new  information 
concerning the interpretation of kidney data from this 13-week study in rats and considered that EFSA 
implemented  new  methodology  in  its  exposure  assessment.  Therefore,  the  European  Commission 
requested  EFSA  to  reconsider  the  established  ADI  and  to  refine  the  exposure  assessment  of  its 
previous opinion. 
The  Panel  was  provided with supplementary  information  on the  evaluation of  the significance  of 
kidney changes (Hard, 2012), previously observed by Edwards et al (2007) and Perry and Shearer 
(2008). The Panel evaluated the new report (Hard, 2012) reviewing the significance of eosinophilic 
droplets in the kidneys of rats of both sexes observed at all dose levels of β-apo-8‟-carotenal active 
ingredient/kg bw/day. The material was most prominent in the cortical tubules of female rats exposed 
to 100 mg/kg bw/day. Hard (2012) suggested that it was very likely that the eosinophilic material 
represented accumulation of the test compound or a derivative during normal renal processing. The 
persistence of a reduced amount of the accumulating material in proximal convoluted tubule cells of 
the kidneys at the end of the 4-week recovery period indicated that the material was eliminated, but at 
a relatively slow rate (Hard, 2012). At the high dose of 100 mg/kg bw/day, a rare condition of cell 
detachments was suspected, accompanied by very occasional mitotic figures, which suggested that the 
normal  ability  of  the  proximal  tubule  to  repair  proximal  convoluted  tubule  cells  affected  by  the 
accumulated material might have marginally been exceeded at this dose. Based on these observations, 
the author concluded that 30 mg/kg bw/day represented a no observed adverse effect level (NOAEL), 
since no microscopic evidence of tubule injury was observed at this dose. The Panel agreed with this 
conclusion. 
The Panel concluded that based on the NOAEL of 30 mg/kg bw/day from the 13-week study in rats, in 
which tubular cell injury was observed at 100 mg/kg bw/day, and using an uncertainty factor of 100, 
an  ADI  for  β-apo-8‟-carotenal  of  0.3  mg/kg  bw/day  was  established.  The  Panel  considered  an 
uncertainty factor of 100 as sufficient, not needing an extra adjusting factor due to the pivotal study 
being a subchronic study (and not a chronic study), given the fact that tubular injury was not observed 
in the two-year study at 40 mg/kg bw/day, the single dose tested. 
Scenarios  used  for  the  exposure  assessment  based  on  the  MPLs  or  use  levels  in  reported  food 
categories combined with the MPLs for other categories led to an exceedance of the ADI up to 10-20 
fold in all population groups, both at mean and high level exposure.  
However, a further refined exposure scenario was based only on the limited number of categories 
where industry reported use levels and analytical data. Exposure estimates using this scenario were 
below the ADI at the mean level for all population groups. At high level of exposure, the ADI was 
exceeded for toddlers and children, and the exposure for adolescents was at about the ADI. The Panel 
considered  that  this  high  level  exposure  estimate  was  still  conservative  and  concluded  that  these 
exceedances are unlikely to occur. The Panel concluded that the uses and use levels of  β-apo-8‟-
carotenal (E 160e), as reported by the food industry, would not be of safety concern.  
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION 
Following a request from the European Commission to the European Food Safety Authority (EFSA), 
the Panel on Food Additives and Nutrient Sources added to Food was asked to deliver a scientific 
opinion reevaluating the safety of β-apo-8‟-carotenal (E 160e) as a food additive. The European Food 
Safety  Authority  has  re-evaluated  the  safety  of  β-apo-8‟-carotenal  (E 160e)  in  2012  (EFSA  ANS 
Panel, 2012). In this re-evaluation EFSA established an ADI for β-apo-8‟-carotenal (E 160e) at 0.05 
mg/kg bw/day.  
After  the  publication  of  the  EFSA  opinion,  the  European  Commission  received  new  information 
concerning the interpretation of kidney data from a 13-week study in rats and considered the fact that 
meanwhile EFSA implemented new methodology in its exposure assessment. Therefore, the European 
Commission requested EFSA to reconsider the established ADI and to refine the exposure assessment 
of its previous opinion. 
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
In accordance with Article 29 (1)(a) of Regulation (EC) No 178/2002, the European Commission 
asked EFSA to consider newly submitted information on the interpretation of the 13-week study in rats 
used as a basis to derive the ADI, to clarify its impact on the established ADI and to carry out the 
refined exposure assessment of β-apo-8‟-carotenal. 
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EVALUATION 
1.  Introduction 
Following a request from the European Commission (EC) to the European Food Safety Authority 
(EFSA), the Panel on Food Additives and Nutrient Sources added to Food (ANS) delivered a scientific 
opinion reevaluating the safety of β-apo-8′-carotenal (E 160e) when used as a food colour. 
In this re-evaluation (EFSA ANS Panel, 2012), a subchronic 13-week study with β-apo-8′-carotenal 
10 % WS/N in rats, given doses of 0, 10, 30 and 100 β-apo-8′-carotenal active ingredient/kg body 
weight (bw)/day (Edwards et al., 2007; Perry and Shearer, 2008), was used to establish an acceptable 
daily intake (ADI). Histopathologically, administration of β-apo-8′-carotenal 10 % WS/N in the diet 
was associated with eosinophilic droplets in the kidneys of both sexes at 10 mg β-apo-8′-carotenal 
active ingredient/kg bw/day and above; multinucleate hepatocytes (MNH) in the liver of females at 
30 mg  β-apo-8′-carotenal  active  ingredient/kg  bw/day  and  above;  and  increased  numbers  of 
inflammatory  cell  foci  in  the  liver  of  females  at  100 mg  β-apo-8′-carotenal  active  ingredient/kg 
bw/day. The Panel concluded that the presence of MNH as observed in this study was reversible and 
not adverse. The Panel, however, noted that the finding of eosinophilic droplets in the kidney of all 
exposed groups suggests the kidney as the target organ. 
The Panel evaluated the data on the eosinophilic droplets in the kidneys of both sexes at 10 mg β-apo-
8′-carotenal  active  ingredient/kg  bw/day  and  above.  From  these  data,  the  Panel  concluded  that 
10 mg/kg bw/day is a lowest observed adverse effect level (LOAEL) for this effect, and established an 
ADI of 0.05 mg/kg bw/day for β-apo-8′-carotenal (E 160e). 
After  the  publication  of  the  EFSA  opinion,  the  EC  received  new  information  concerning  the 
interpretation  of  the  kidney  data  from  this  13-week  study  in  rats  and  considered  that  EFSA 
implemented new methodology in its exposure assessment. Therefore, the EC requested EFSA to 
reconsider the established ADI and to refine the exposure assessment of its previous opinion. 
2.  Evaluation of new toxicological data 
2.1.  Re-examination of the renal histological changes occurring in the 13-week study in rats 
The  Panel  was  provided with supplementary  information  on the  evaluation of  the significance  of 
kidney changes (Hard, 2012) previously observed by Edwards et al. (2007) and Perry and Shearer 
(2008). Hard (2012), an experienced expert in renal pathology, re-examined the kidney slides under 
improved visualisation conditions using an Olympus BX41 microscope, under both brightfield and 
ultraviolet using objectives ranging from 4- 40  magnification. 
The  main  change  associated  with  β-apo-8′-carotenal  exposure  appeared  to  be  the  presence  of  ill-
defined clumps of droplets of eosinophilic material in the cytoplasm of the proximal convoluted tubule 
cells of the kidneys. This change was particularly evident in the female rats, ranging from minimal 
involvement of cortical tubules at the low dose (10 mg/kg bw/day) to virtually all cortical tubules 
(mild to moderate in severity) at the high dose (100 mg/kg bw/day). The report suggested that the 
eosinophilic material represented accumulation of the test material, which caused no apparent injury to 
the tubule cells, except in the high-dose animals. In these animals some slight changes were reported 
(cell  detachments  and  very  occasional  mitotic  figures),  which  were  ascribed  to  the  marginally 
exceeded ability of the tubules to deal with the accumulated material. Therefore, the report concluded 
that 30 mg/kg bw/day represented a no observed adverse effect level (NOAEL), since no microscopic 
evidence  of  tubule  injury  was  observed  at  this  dose  (Hard,  2012).  The  Panel  agreed  with  this 
conclusion, but noted that no analysis of the accumulated material has been provided to demonstrate 
that it was related to the test material.  
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3.  Exposure assessment of β-apo-8′-carotenal (E 160e) 
In its 2012 opinion, the ANS Panel had evaluated the exposure to β-apo-8‟-carotenal (E 160e) on the 
basis of the uses and use levels authorised in the legislation and the reported use levels, as provided by 
industry, and concluded that for exposure estimates at tier 3, the ADI of 0.05 mg/kg bw was reached at 
the mean, and exceeded at the 95
thpercentile of exposure for adults, and both at the mean and the 
95
th/97.5
th percentile for children (EFSA ANS Panel, 2012). 
Table 1:   Summary of anticipated exposure to β-apo-8‟-carotenal (E 160e) in children and the adult 
population (EFSA ANS Panel, 2012) 
 
Adult UK 
population 
(> 18 years old) 
(mg/kg bw/day) 
Children 
UK and EXPOCHI population 
(1-10 years old, 15.8-29 kg body weight) 
(mg/kg bw/day) 
Tier 1. Budget method   8.1  13.1 
Tier 2. Maximum permitted level 
  Mean exposure 
  Exposure 95
th or 97.5
th percentile
(a) 
 
0.9 
3.3 
 
0.5 – 3.4 
1.2 – 7.2 
Tier 3. Maximum reported use levels  
  Mean exposure 
  Exposure 95
th or 97.5
th percentile
(a) 
 
0.05 
0.19 
 
0.02 – 0.22 
0.09 – 0.71 
(a): For the UK population, estimates were based on the UNESDA report which gives the 97.5
th percentile (Tennant, 2006). 
For UK adults, the main contributors (> 10 %) to the total anticipated mean exposure to β-apo-8‟-
carotenal  (E  160e)  were  non-alcoholic  flavoured  drinks  (92  %),  while  for  children,  the  main 
contributors were non-alcoholic flavoured drinks (50-91%) and fine bakery wares (11-50 %). 
3.1.  Maximum permitted levels of use of β-apo-8’-carotenal (E 160e) 
Maximum permitted levels (MPLs) of β-apo-8‟-carotenal (E 160e) have been defined in the Annex II 
of Regulation (EC) No 1333/2008
4 on food additives for use in foodstuffs. 
Currently, β-apo-8‟-carotenal (E 160e) is an authorised food colour in the EU with MPLs ranging from 
50 to 500 mg/kg in foods. The use of β-apo-8‟-carotenal (E 160e) is permitted in flavoured processed 
cheese, fish paste and crustacean paste, precooked crustacean and smoked fish, individually or  in 
combination with other food colours.
5 β-Apo-8‟-carotenal (E 160e) is also included in the Group III of 
food colours authorised with a combined maximum limit (Regulation (EC) No 1333/2008) (Table 2). 
                                                       
4  Regulation (EC) No 1333/2008 of the European Parliament and of the Council on food additives. OJ L 354, 31.12.2008, p. 
16. 
5  Combinations with the following food colours are considered: E 100, E 102, E 104, E 110, E 120, E 122, E 124,  E 129, E 
142, E 151 and E 161b.  
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Table 2:   MPLs of β-apo-8‟-carotenal (E 160e) in foods according to the Annex II of Regulation  
  (EC) No 1333/2008 
FCS 
category 
number 
Foods  Restrictions/exceptions 
Maximum level  
(mg/l or mg/kg 
as appropriate) 
1.4 
Flavoured fermented milk 
products including heat-treated 
products    150 
1.6.3  Other creams  only flavoured creams  150 
1.7.1  Unripened cheese excluding 
products falling in category 16  only flavoured unripened cheese  150 
1.7.3  Edible cheese rind    QS 
1.7.5  Processed cheese  only flavoured processed cheese  100
(a) 
1.7.6  Cheese products (excluding 
products falling in category 16)  only flavoured unripened products  100 
3  Edible ices    150 
4.2.4.1  Fruit and vegetable preparations 
excluding compote  only mostarda di frutta  200 
5.2.  Other confectionery including 
breath freshening microsweets  except candied fruit and vegetables  300 
5.2.  Other confectionery including 
breath freshening microsweets  only candied fruit and vegetables  200 
5.3.  Chewing gum    300 
5.4. 
Decorations, coatings and 
fillings, except fruit-based 
fillings covered by category 4.2.4 
only decorations, coatings and sauces, 
except fillings  500 
5.4. 
Decorations, coatings and 
fillings, except fruit-based 
fillings covered by category 4.2.4 
only fillings  300 
6.6  Batters  only batters for coating  500 
7.2.  Fine bakery wares    200 
8.2.3  Casings and coatings and 
decorations for meat  
only decorations and coatings except 
edible external coating of pasturmas  500 
8.2.3  Casings and coatings and 
decorations for meat  only edible casings  QS 
9.2. 
Processed fish and fishery 
products including molluscs and 
crustaceans 
only fish paste and crustacean paste  100
(b) 
9.2. 
Processed fish and fishery 
products including molluscs and 
crustaceans 
only surimi and similar products and 
salmon substitutes  500 
9.2. 
Processed fish and fishery 
products including molluscs and 
crustaceans 
only precooked crustacean  250
(c) 
9.2 
Processed fish and fishery 
products including molluscs and 
crustaceans 
Only smoked fish  100
(d) 
9.3  Fish roe  except Sturgeons' eggs (Caviar)  300 
12.2.2  Seasonings and condiments   only seasonings, for example curry 
powder, tandoori  500 
12.4  Mustard    300 
12.5  Soups and broths    50 
12.6  Sauces 
including pickles, relishes, chutney and 
piccalilli; excluding tomato-based 
sauces 
500 
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Table 2 :  MPLs of β-apo-8‟-carotenal (E 160e) in foods according to the Annex II of Regulation  
  (EC) No 1333/2008 continued. 
 
FCS 
category 
number 
Foods  Restrictions/exceptions 
Maximum level  
(mg/l or mg/kg 
as appropriate) 
12.9  Protein products, excluding 
products covered in category 1.8 
only meat and fish analogues based on 
vegetable proteins  100 
13.2 
Dietary foods for special medical 
purposes defined in Directive 
1999/21/EC (excluding products 
from food category 13.1.5) 
  50 
13.3 
Dietary foods for weight control 
diets intended to replace total 
daily food intake or an individual 
meal (the whole or part of the 
total daily diet) 
  50 
14.1.4  Flavoured drinks  excluding chocolate milk and malt 
products  100 
14.2.3  Cider and perry  excluding cidre bouché  200 
14.2.4  Fruit wine and made wine     200 
14.2.6  Spirit drinks as defined in 
Regulation (EC) No 110/2008 
except: spirit drinks as defined in 
article 5(1) and sales denominations 
listed in Annex II, paragraphs 1-14 of 
Regulation (EC) No 110/2008 and 
spirits (preceded by the name of the 
fruit) obtained by maceration and 
distillation, London Gin, Sambuca, 
Maraschino, Marrasquino or 
Maraskino and Mistrà 
200 
14.2.7.1  Aromatised wines   Except americano, bitter vino  200 
14.2.7.2  Aromatised wine-based drinks  except bitter soda, sangria, claria, 
zurra  200 
14.2.7.3  Aromatised wine-product 
cocktails     200 
14.2.8 
Other alcoholic drinks including 
mixtures of alcoholic drinks with 
non-alcoholic drinks and spirits 
with less than 15 % of alcohol 
only alcoholic drinks with less than 
15 % of alcohol  200 
15.1  Potato-, cereal-, flour- or starch-
based snacks 
excluding extruded or expanded 
savoury snack products  100 
15.1  Potato-, cereal-, flour- or starch-
based snacks 
only extruded or expanded savoury 
snack products  200 
15.2  Processed nuts  only savoury-coated nuts  100 
16  Desserts excluding products 
covered in categories 1, 3 and 4    150 
17.1 
Food supplements supplied in a 
solid form including capsules 
and tablets and similar forms, 
excluding chewable forms  
  300 
17.2  Food supplements supplied in a 
liquid form    100 
17.3  Food supplements supplied in a 
syrup-type or chewable form  only solid food supplements  300 
17.3  Food supplements supplied in a 
syrup-type or chewable form  only liquid food supplements  100 
(a):  Maximum individually or for the combination of E 100, E 102, E 104, E 110, E 120, E 122, E 124, E 160e and E 161b  
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(b):  Maximum individually or for the combination of E 102, E 104, E 110, E 120, E 122, E 124, E 142, E 151, E 160e and E 
161b 
(c):  Maximum individually or for the combination of E 102, E 110, E 120, E 122, E 124, E 129, E 142, E 151, E 160e and E 
161b 
(d):  Maximum individually or for the combination of E 102, E 110, E 120, E 124, E 151 and E 160e 
   QS, quantum satis 
3.2.  Reported use levels or data on analytical levels of β-apo-8’-carotenal (E 160e) 
Most food additives in the EU are authorised at a specific MPL. However, a food additive may be used 
at a lower level than the MPL. For those additives where no MPL is set and which are authorised as 
quantum satis (QS), information on actual use levels is required.  
In December 2006, EFSA issued a public call
6 for scientific data on  β-apo-8‟-carotenal (E 160e), 
including present use and use patterns (i.e. which food categories and subcategories, proportion of 
food within categories/subcategories in which it is used, actual use levels (typical and maximum use 
levels),  especially  for  those  uses  which  are  only  limited  by  quantum  satis).  In  addition,  in  the 
framework of Regulation (EC) No 1333/2008 on food additives and of Regulation (EU) No 257/2010 
regarding the re-evaluation of approved food additives, in 2013 EFSA issued a new public call
7 for 
concentration data (usage and/or analytical data) on β-apo-8‟-carotenal (E 160e). 
In response to the public call for concentration data launched in March 2013, updated information on 
the actual use levels of β-apo-8‟-carotenal (E 160e) in foods was made available to EFSA for some 
food categories of finished products by FoodDrinkEurope (FDE), the Natural Colours Association 
(NATCOL), the International Chewing Gum Association (ICGA) and the Association of the European 
Self-Medication Industry (AESGP). In addition, some analytical data on β-apo-8‟-carotenal (E 160e) 
in soft drinks have been provided from one Member State (Cyprus). 
Summarised data on reported use levels in foods from industries and other sources 
Appendix  A  presents  data  on  the  levels  of  β-apo-8‟-carotenal  (E  160e)  in  foods  as  reported  by 
industries in September and October 2013. 
Usage levels of β-apo-8‟-carotenal (E 160e) in food were provided for the following food categories: 
confectionery,  chewing  gum,  decorations,  coatings  and  fillings,  processed  fish,  seasonings  and 
condiments, soups and broths, sauces, flavoured drinks and food supplements. Additional data on β-
apo-8‟-carotenal (E 160e) concentration in a relatively small number of samples in food (n=12) and 
beverages  (n=7)  were  provided:  for  cheese  (n=1),  confectionery  (n=7),  fine  bakery  wares  (n=2), 
desserts (n=2) and flavoured drinks (n=7). Some information was also provided on the frequency of 
occurrence of β-apo-8‟-carotenal in different foods and beverages in the market (Tennant, 2013). 
Analytical data (n=47) on β-apo-8‟-carotenal (E 160e) in soft drinks (juices, nectars and flavoured 
drinks) were also provided from a national monitoring programme from one Member State (Cyprus). 
Some samples (n=9) showed the presence of β-apo-8‟-carotenal (E 160e) in food categories (14.1.2 – 
juices  and  14.1.3  –  nectars)  where  this  food  additive  is  not  authorised  (Regulation  (EC)  No 
1333/2008). Of the remaining ones, referring to flavoured drinks (food category 14.1.4 - excluding 
chocolate milk and malt products), the majority (n=32) were below the limit of detection (LOD), 
whereas the few values reported above the LOD (n=6) were above the MPL authorised for β-apo-8‟-
carotenal (E 160e) in this food category (100 mg/l). Data resulting from non-authorised uses or above 
MPL  from  authorised  uses  of  β-apo-8‟-carotenal  (E  160e)  were  not  considered  in  the  exposure 
assessment. 
                                                       
6  Call for scientific data on food colours to support re-evaluation of all food colours authorised under the EU legislation. 
Published: 8 December 2006. http://www.efsa.europa.eu/en/dataclosed/call/afc061208.htm  
7  Call for food additives usage level and/or concentration data in food and beverages intended for human consumption. 
Published: 27 March 2013. http://www.efsa.europa.eu/en/data/call/130327.htm   
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3.3.  Food consumption 
3.3.1.  EFSA Comprehensive European Food Consumption Database 
In 2010, the EFSA Comprehensive European Food Consumption Database (Comprehensive Database) 
was  built  from  existing  national  information  on food  consumption  at  a  detailed  level.  Competent 
authorities in the European countries provided EFSA with data on the level of food consumption by 
the individual consumer from the most recent national dietary survey in their country (cf. Guidance of 
EFSA  „Use  of  the  EFSA  Comprehensive  European  Food  Consumption  Database  in  Exposure 
Assessment‟ (EFSA, 2011a). 
Overall, the food consumption data gathered at EFSA were collected by different methodologies and 
thus direct country-to-country comparison should be made with caution. 
Anticipated  exposure  to  β-apo-8‟-carotenal  (E  160e)  from  its  use  as  a  food  additive  has  been 
calculated  (mean  and  95
th  percentile  of  consumers  only)  using  the  food  consumption  data  at  the 
individual  level  (e.g.  raw  data  on  food  consumption  by  the  individual  consumer).  High  level 
consumption was only calculated for those foods and population groups where the sample size was 
sufficiently  large  to  allow  calculation  of  the  95
th  percentile  (EFSA,  2011a).  The  Panel  estimated 
chronic exposure for the following population groups: toddlers, children, adolescents, adults and the 
elderly. Calculations were performed using individual body weights. 
Thus, for the present assessment, food consumption data were available from 26 different dietary 
surveys carried out in 17 different European countries (Table 3). 
Table 3:   Population groups considered for the exposure estimates of β-apo-8‟-carotenal (E 160e) 
Population  Age range  Countries with food consumption surveys 
covering more than one day 
Toddlers  from  12  up  to  and  including  35 
months of age 
Belgium,  Bulgaria,  Finland,  Germany,  Italy 
Netherlands, Spain 
Children
8  from 36 months up to and including 
9 years of age  
Belgium,  Bulgaria,  Czech  Republic,  Denmark, 
Finland,  France,  Germany,  Greece,  Italy,  Latvia, 
Netherlands, Spain, Sweden  
Adolescents  from  10  up  to  and  including  17 
years of age  
Belgium,  Cyprus,  Czech  Republic,  Denmark, 
France, Germany, Italy, Latvia, Spain, Sweden 
Adults  from  18  up  to  and  including  64 
years of age 
Belgium,  Czech  Republic,  Denmark,  Finland, 
France,  Germany,  Hungary,  Ireland,  Italy,  Latvia, 
Netherlands, Spain, Sweden, UK  
The elderly
8   Older than 65 years  Belgium,  Denmark,  Finland,  France,  Germany, 
Hungary, Italy 
 
Consumption records in the EFSA Comprehensive Database were codified according to the FoodEx 
classification system (EFSA, 2011b). Nomenclature from the FoodEx classification system was linked 
to  the  Food  Classification  System  (FCS)  as  presented  in  the  Annex  II  of  Regulation  (EC) 
No 1333/2008, part D, to perform exposure estimates. 
3.3.2.  Food items selected for the refined exposure assessment of β-apo-8’-carotenal (E 160e) 
The food categories in which the use of β-apo-8‟-carotenal (E 160e) is authorised were selected from 
the nomenclature of the Comprehensive Database (FoodEx classification system codes), at a detailed 
level (up to FoodEx level 3) (EFSA, 2011a).  
                                                       
8   The terms “children” and “the elderly” correspond respectively to “other children” and the merge of “elderly” and “very 
elderly” in the Guidance of EFSA on the „Use of the EFSA Comprehensive European Food Consumption Database in 
Exposure Assessment‟ (EFSA, 2011b).  
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Some foods in which the use of β-apo-8‟-carotenal (E 160e) is authorised are not referenced in the 
FoodEx classification system and therefore could not be taken into account in the present exposure 
assessment. These are described below (in ascending order of the Food Classification System codes): 
-  1.7.3. Edible cheese rind: this food category is not referenced in the FoodEx classification 
system. 
-  1.7.6.  Cheese  products  (excluding  products  falling  in  category 16),  only  flavoured 
unripened  products:  all  flavoured  cheeses  or  analogues  are  gathered  under  "processed 
cheese" (category number 1.7.5), no food items correspond to this category in the FoodEx 
category  
-  4.2.4.1. Fruit and vegetable preparations excluding compote, only mostarda di frutta: 
this item is not referenced in the FoodEx nomenclature, even at the original food name level. 
Therefore, it was not taken into account.  
-  5.4. Decorations, coatings and fillings, except fruit based fillings covered by category 
4.2.4: this category covers any confectionery product generally used for decorating and filling 
any foodstuff e.g. fine bakery wares, edible ices, candy and confections. This food category is 
not  available  in  the  FoodEx  nomenclature,  but  foodstuffs  that  are  likely  to  be  filled  or 
decorated (e.g. fine bakery wares) are included in the assessment. 
-  6.6. Batters: as for decorations and coatings, batters represent a part of a composite food and 
are not referenced in the FoodEx nomenclature. This category was not taken into account in 
the present estimates. 
-  8.2.3. Casings, coatings and decorations for meat: this food category is not referenced in the 
FoodEx classification system and therefore not taken into account. 
-  14.2.4. Fruit wine and made wine: this category includes wine made from fruits other than 
grapes and apples and from other agricultural products, including grains; it may be still or 
sparkling  (e.g.  rice  wine,  sake).  No  such  category  of  wines  is  present  in  the  FoodEx 
nomenclature. 
This results in an underestimation of exposure.  
Other limitations of the current exposure estimates, which are due to the linkage between the FoodEx 
classification system and the FCS (Annex II of Regulation (EC) No 1333/2008), are listed below (in 
ascending order of FCS codes). This results in an overestimation of exposure: 
-  5.2. Other confectionery including breath freshening microsweets: it is not possible within 
the FoodEx to differentiate candied fruits and vegetables, therefore the MPL of 300 mg/kg was 
assigned to the entire food group. 
-  9.2. Processed fish and fishery products including mollusks and crustaceans:  it is not 
possible  within  FoodEx  to  differentiate  fish  paste,  crustacean  paste,  surimi,  precooked 
crustacean and smoked fish. Thus, the highest MPL was assigned to the whole food group i.e. 
500 mg/kg. 
-  15.1. Potato-, cereal-, flour- or starch-based snacks: the MPL of 200 mg/kg was applied to 
the whole food group. 
-  17. Food supplements: it is not possible to differentiate the form of the food supplements 
within FoodEx codes, thus the MPL of 300 mg/kg was applied for the whole food group of 
food supplements.  
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For  the following  food  groups, the restrictions as  provided in the  legislation were  not taken into 
account and food consumption data corresponding to the entire food groups were used to perform the 
exposure estimate: 
-  1.6.3. Other creams: the restriction „only flavoured creams‟ could not be taken into account. 
The entire food category „1.6 – creams‟ was considered in the exposure assessment. 
-  1.7.1. Unripened cheese, excluding products falling in category 16: the restriction „only 
flavoured unripened cheese‟ could not be taken into account. 
-  1.7.5. Processed cheese: the restriction „only flavoured processed cheese‟ could not be taken 
into account. 
-  12.2.2.  Seasonings  and  condiments:  the  entire  food  category  12.2  „seasonings  and 
condiments‟ was considered in the exposure assessment. 
-  12.6. Sauces: the entire food category was considered, including tomato-based sauces. 
-  12.9. Protein products, excluding products covered in category 1.8: the restriction „only 
meat  and  fish  analogues  based  on  vegetable  proteins‟  was  not  taken  into  account  in  the 
exposure assessment. 
For the following food categories, further refinements were made: 
-  14.1.4. Flavoured drinks: chocolate milk and malt products, as well as cola beverages, which 
are not likely to contain β-apo-8‟-carotenal, were excluded from the exposure estimate. 
-  14.2. Alcoholic beverages, including alcohol-free and low-alcohol counterparts: beers and 
wines were not taken into account in the exposure estimates, as these are not likely to contain 
β-apo-8‟-carotenal, but restrictions applying to other alcoholic beverages could not be taken 
into account. 
For food categories not mentioned above, foods from the Comprehensive Database were chosen in 
accordance with the legislation (Table 2). 
3.3.3.  Exposure to β-apo-8’-carotenal (E 160e) from its use as a food additive 
Dietary exposure to β-apo-8‟-carotenal (E 160e) from its use as a food additive was calculated by 
using (1) MPLs as listed in Table 2, and by using (2) data on reported levels or analytical data as 
provided by industry and listed in Appendix B, both combined with national consumption data for the 
five population groups (Table 3). 
Two scenarios were taken into account when reported use levels were considered. In the first scenario 
(UL1), maximum reported levels provided by industries were used. When no actual usage levels for β-
apo-8‟-carotenal (E 160e) were provided to EFSA for a food category, it was assumed that β-apo-8‟-
carotenal (E 160e) is not used in this food category. When more than one levels for β-apo-8‟-carotenal 
(E 160e) were reported by industry in a given food category, the highest level provided was used in the 
exposure assessment. 
For the second scenario (UL2), where no reported data had become available to EFSA for a food 
category, the MPL was used for this food category. For food categories where analytical data were 
available, these were not taken into account in the exposure calculation; instead, the MPL or usage 
data, were used. 
Table 4 summarises the estimated exposure to β-apo-8‟-carotenal (E 160e) from its use as a food 
additive for all five population groups.  
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Table 4:   Summary of anticipated exposure to β-apo-8‟-carotenal (E 160e) from its use as a food 
additive, by age class (mg/kg bw/day). The minimum and maximum of mean and 95
th 
percentile estimated exposure values across European dietary surveys are shown. 
  Toddlers  Children  Adolescents  Adults  The elderly  
  (12-35 months)  (3-9 years)  (10-17 years)  (18-64 years)  (> 65 years) 
Estimated exposure using 
MPLs 
         
  Mean  
  High level
9 
1.0-3.9 
2.8-7.4 
1.0-3.3 
2.4-6.7 
0.5-1.7 
1.0-3.4 
0.3-1.1 
0.8-2.4 
0.2-0.6 
0.6-1.5 
Estimated exposure using 
reported use levels or 
analytical data (UL1) 
         
  Mean 
  High level
9 
0.02-0.25 
0.06-0.49 
0.02-0.24 
0.07-0.46 
0.02-0.14 
0.07-0.32 
0.01-0.09 
0.04-0.20 
0.01-0.06 
0.04-0.14 
Estimated exposure using 
reported use levels (UL2) 
         
  Mean 
  High level
9 
0.9-2.5 
2.4-6.1 
0.7-2.2 
1.4-5.1 
0.2-0.8 
0.5-1.8 
0.2-0.5 
0.4-1.2 
0.1-0.4 
0.4-0.9 
3.3.4.  Main food categories contributing to exposure  to β-apo-8’-carotenal (E 160e) using 
MPLs 
Table 5:   Main food categories contributing to exposure to β-apo-8‟-carotenal (E 160e) using MPLs 
(> 5 % to the total mean exposure) and number of surveys in which each food category is 
contributing. 
 
   Toddlers  Children  Adolescents  Adults  The 
elderly  
FCS 
category 
number 
Foods  range of % contribution to the total exposure  
(Number of Surveys) 
(a) 
1.4 
Flavoured fermented milk 
products including heat-treated 
products 
6-69 
(7) 
1-35 
(13) 
1-14 
(9) 
0-31 
(12) 
4-28 
(6) 
7.2  Fine bakery wares  2-51 
(6) 
4-46 
(13) 
3-45 
(11) 
0-42 
(14) 
0-31 
(6) 
14.1.4.1  Flavoured drinks with sugar  0-20 
(4) 
3-43 
(14) 
5-55 
(12) 
3-42 
(12) 
1-38 
(3) 
3  Edible ices  0-14 
(2) 
2-12 
(10) 
2-10 
(3) 
1-9 
(3) 
0-6 
(2) 
16  Desserts excluding products 
covered in categories 1, 3 and 4 
0-13 
(2) 
0-10 
(5) 
0-7 
(1) 
0-5 
(2) 
0-7 
(1) 
12.6  Sauces  0-12 
(4) 
1-23 
(12) 
2-33 
(10) 
3-33 
(14) 
3-27 
(6) 
1.7.5  Processed cheese  0-11 
(2)  -  -  -  - 
14.1.4.2  Flavoured drinks with sweeteners  0-8 
(1) 
0-6 
(3) 
0-15 
(4) 
0-24 
(5) 
0-6 
(1) 
1.7.1  Unripened cheese (excluding 
products falling in category 16) 
0-7 
(4) 
0-15 
(4) 
0-18 
(1) 
1-24 
(6) 
2-22 
(5) 
 
 
 
                                                       
9 Typically the 95
th percentile of consumers only.  
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Table 5 :  Main food categories contributing to exposure to β-apo-8‟-carotenal (E 160e) using 
MPLs (> 5 % to the total mean exposure) and number of surveys in which each food 
category is contributing continued. 
 
 
     Toddlers  Children  Adolescents  Adults  The 
elderly  
FCS 
category 
number 
Foods  range of % contribution to the total exposure  
(Number of Surveys) (a) 
14.2 
Alcoholic beverages, including 
alcohol-free and low-alcohol 
counterparts 
-  -  -  1-18 
(6) 
1-13 
(4) 
12.5  Soups and broths  0-6 
(1) 
0-13 
(3) 
0-12 
(1) 
0-16 
(3) 
0-16 
(2) 
12.2  Herbs, spices, seasonings  0-8 
(2) 
0-5 
(1) 
0-11 
(1) 
0-15 
(1) 
0-17 
(1) 
9.2 
Processed fish and fishery 
products including mollusks 
and crustaceans 
0-8 
(2) 
0-15 
(5) 
0-7 
(4) 
0-10 
(3) 
0-5 
(1) 
5.2.1  Other confectionery with added 
sugar  -  0-10 
(6) 
0-10 
(3) 
0-9 
(2) 
0-6 
(1) 
1.6  Cream  0-6 
(1) 
0-7 
(1)  -  1-13 
(4) 
1-14 
(3) 
15.1  Potato-, cereal-, flour- or starch-
based snacks 
0-7 
(2) 
1-5 
(1) 
1-9 
(3)  -  - 
(a): The total number of surveys may be greater than the total number of countries listed in Table 3, as some countries 
submitted more than one survey for a specific age range.  
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3.3.5.  Main  food  categories  contributing  to  exposure  to  β-apo-8’-carotenal  (E  160e)  using 
reported use levels or reported data on analytical levels 
Table 6:   Main  food  categories  contributing  to  exposure  to  β-apo-8‟-carotenal  (E  160e)  using 
reported  use  levels  or  reported  data  on  analytical  levels  (>  5  %  to  the  total  mean 
exposure) following scenario 1 (UL1) and number of surveys in which each food category 
is contributing. 
 
   Toddlers  Children  Adolescents  Adults  The 
elderly  
FCS 
category 
number 
Foods  range of % contribution to the total exposure  
(Number of Surveys) 
(a) 
14.1.4.1  Flavoured drinks with sugar  0-40 
(4) 
9-55 
(15) 
8-80 
(12) 
4-73 
(14) 
3-73 
(5) 
12.6  Sauces  1-29 
(6) 
2-41 
(14) 
3-43 
(11) 
10-55 
(15) 
8-55 
(7) 
5.2.1  Other confectionery with added 
sugar 
4-36 
(6) 
5-56 
(15) 
2-35 
(11) 
0-39 
(10) 
0-33 
(3) 
12.5  Soups and broths  0-28 
(4) 
0-42 
(7) 
0-41 
(5) 
0-51 
(7) 
0-51 
(3) 
12.2  Herbs, spices, seasonings  0-26 
(3) 
0-18 
(2) 
0-35 
(1) 
0-44 
(4) 
0-43 
(3) 
16  Desserts excluding products 
covered in categories 1, 3 and 4 
0-44 
(3) 
0-14 
(4) 
0-11 
(1) 
0-9 
(2) 
0-12 
(1) 
14.1.4.2  Flavoured drinks with sweeteners  0-20 
(3) 
0-12 
(6) 
0-18 
(4) 
0-30 
(8) 
0-9 
(2) 
7.2  Fine bakery wares  2-21 
(4) 
1-27 
(8) 
1-20 
(8) 
0-18 
(10) 
0-14 
(4) 
9.2 
Processed fish and fishery 
products including mollusks and 
crustaceans 
0-8 
(2) 
0-20 
(2) 
0-6 
(2)  -  - 
5.2.2  Other confectionery without 
added sugar  -  -  -  -  - 
17. 
Food supplements as defined in 
Directive 2002/46/EC excluding 
food supplements for infants and 
young children 
0-11 
(1)  -  -  0-19 
(5) 
0-49 
(2) 
(a): The total number of surveys may be greater than the total number of countries listed in Table 2, as some countries 
submitted more than one survey for a specific age range.  
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Table 7:   Main food categories contributing to exposure to β-apo-8‟-carotenal (E 160e) using 
  reported use levels or reported data on analytical levels (> 5 % to the total mean 
  exposure) 
  following scenario 2 (UL2) and number of surveys in which each food category is 
  contributing. 
 
   Toddlers  Children  Adolescents  Adults  The 
elderly  
FCS 
category 
number 
Foods  range of % contribution to the total exposure  
(Number of Surveys) 
(a) 
1.4 
Flavoured fermented milk 
products including heat-treated 
products 
8-77 
(7) 
2-46 
(13) 
2-29 
(10) 
1-42 
(14) 
6-35 
(7) 
7.2  Fine bakery wares  3-66 
(6) 
5-67 
(15) 
9-56 
(12) 
0-55 
(14) 
0-49 
(6) 
1.7.1  Unripened cheese (excluding 
products falling in category 16) 
0-10 
(6) 
0-19 
(7) 
0-24 
(4) 
1-31 
(9) 
4-29 
(5) 
14.2 
Alcoholic beverages, including 
alcohol-free and low-alcohol 
counterparts 
-  -  0-5 
(1) 
2-31 
(10) 
1-17 
(4) 
5.2.1  Other confectionery with added 
sugar 
0-5 
(1) 
1-23 
(7) 
1-27 
(7) 
0-21 
(5) 
0-8 
(2) 
1.6  Cream  0-6 
(1) 
0-9 
(3) 
0-9 
(2) 
1-25 
(4) 
1-25 
(3) 
3  Edible ices  0-20 
(3) 
3-21 
(14) 
5-14 
(12) 
1-12 
(10) 
0-7 
(3) 
16  Desserts excluding products 
covered in categories 1, 3 and 4 
0-16 
(3) 
0-13 
(6) 
0-11 
(3) 
0-11 
(3) 
0-10 
(2) 
15.1  Potato-, cereal-, flour- or starch-
based snacks 
0-9 
(2) 
1-6 
(6) 
2-16 
(7) 
1-7 
(5)  - 
14.1.4.1  Flavoured drinks with sugar  -  0-7 
(1) 
0-11 
(2) 
0-7 
(2) 
0-5 
(1) 
1.7.5  Processed cheese  0-12 
(2)  -  -  -  0-5 
(1) 
12.5  Soups and broths  -  0-7 
(1) 
0-7 
(1) 
0-9 
(1) 
0-8 
(1) 
12.6  Sauces  -  0-5 
(1) 
0-7 
(3) 
0-6 
(5)  - 
12.4  Mustard  -  -  -  0-7 
(1) 
0-5 
(1) 
17 
Food supplements as defined in 
Directive 2002/46/EC excluding 
food supplements for infants 
and young children 
-  -  -  -  0-5 
(1) 
(a): The total number of surveys may be greater than the total number of countries listed in Table 2, as some countries 
submitted more than one survey for a specific age range.  
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3.4.  Uncertainty analysis 
Uncertainties  in  the  exposure  assessment  of  β-apo-8‟-carotenal  (E  160e)  have  been  previously 
discussed in the present opinion in the related chapters. In accordance with the guidance provided in 
the EFSA opinion related to uncertainties in dietary exposure assessment (EFSA, 2007), the following 
sources of uncertainties have been considered and are summarised in Table 8: 
Table 8:   Qualitative evaluation of influence of uncertainties 
Sources of uncertainties  Direction
(a) 
Consumption data: different methodologies / representativeness / under 
reporting / misreporting / no portion size standard  +/- 
Extrapolation  from  food  consumption  survey  of  few  days  to  estimate 
chronic exposure  + 
Linkage between reported use levels and food items in the consumption 
database:  uncertainties  on  which  precise  types  of  food  the  use  levels 
refer. 
+/- 
Occurrence data: maximum reported use levels within a food category  +/- 
Exposure model: uncertainty in possible national differences in use levels 
of food categories, data set not fully representative of foods on the EU 
market, exposure calculations based on the maximum reported use levels 
(no use of typical use levels when available) 
+ 
(a): + uncertainty with potential to cause over-estimation of exposure; - uncertainty with potential to cause underestimation of 
exposure. 
3.5.  Discussion 
The Panel evaluated a new report (Hard, 2012) reviewing the significance of eosinophilic droplets in 
the  kidneys  of  both  sexes  observed  at  all  dose  levels  of  β-apo-8‟-carotenal  active  ingredient/kg 
bw/day. The material was most prominent in the cortical tubules of female rats exposed to 100 mg/kg 
bw/day.  Hard  (2012)  suggested  that  it  was  very  likely  that  the  eosinophilic  material  represented 
accumulation of the test compound or a derivative during normal renal processing. The persistence of 
a reduced amount of the accumulating material in proximal convoluted tubule cells of the kidneys at 
the end of the four-week recovery period indicated that the material was eliminated, but at a relatively 
slow rate. However, at the high dose of 100 mg/kg bw/day, a rare condition of cell detachments was 
suspected, accompanied by very occasional mitotic figures, which suggested that the normal ability of 
the proximal tubule to repair proximal convoluted tubule cells affected by the accumulated material 
might have marginally been exceeded at this dose. Based on these observations, the author concluded 
that 30 mg/kg bw/day represented a NOAEL, since no microscopic evidence of tubule injury was 
observed at this dose. The Panel agreed with this conclusion.  
In  its  previous  opinion  (EFSA  ANS  Panel,  2012)  the  Panel  considered  long-term  carcinogenicity 
studies  on  β-apo-8‟-carotenal  (Schärer  and  Studer,  1961).  β-Apo-8'-carotenal  was  administered  at 
approximately 40 mg/kg bw/day to the first generation of Wistar rats and their offspring for a period of 
two years and no adverse effects were identified, including in the kidney. In addition, the NOAELs 
identified in other toxicity studies evaluated in that opinion were all above 30mg/kg bw/day (EFSA 
ANS Panel, 2012). 
The Panel concluded that based on the NOAEL of 30 mg/kg bw/day from the 13-week study in rats, in 
which tubular cell injury was observed at 100 mg/kg bw/day, and using an uncertainty factor of 100, 
an  ADI  for  β-apo-8‟-carotenal  of  0.3  mg/kg  bw/day  was  established.  The  Panel  considered  an 
uncertainty factor of 100 as sufficient, not needing an extra adjusting factor due to the pivotal study 
being a subchronic study (and not a chronic study), given the fact that tubular injury was not observed 
in the two-year study at 40 mg/kg bw/day, the single dose tested. 
The Panel was provided with data on usage levels of β-apo-8‟-carotenal (E 160e) by the food industry 
and with data from the food surveillance system. While the latter were not taken into account for the  
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estimation of exposure due to the small sample size and the few food categories where data were made 
available, the Panel did perform calculations on exposure based on usage levels provided by industry 
in order to refine exposure compared to the previous opinion. However, food industry reported usage 
levels  only  for  some  of  the  food  categories  where  the  additive  is  authorised.  The  Panel  had  no 
evidence to assume that β-apo-8‟-carotenal is indeed used in the reported food categories only but had 
also no evidence that the additive is used in a broader range of categories. Consequently, two different 
scenarios of refined exposure estimates were calculated as outlined in the exposure section.  
Based on the assumption that indeed β-apo-8‟-carotenal (E 160e) is only used in those categories 
where usage levels were provided, exposure estimates were below the ADI of 0.3 mg/kg bw/day for all 
population groups at the mean, but exceeded the ADI at high level consumption for toddlers and 
children and was at the ADI for adolescents. Main contributors in this scenario (UL1) were flavoured 
drinks (up to 80 %), sauces (up to 55 %), other confectionery (up to 56 %), soups and broths (up to 51 
%), and food supplements (up to 49 %).  
Exposure scenarios using either the MPLs or the combination of usage levels provided by industry and 
of  MPLs  for  those  food  categories  were  no  usage  of  the  colour  was  reported  (UL2)  resulted  in 
exceedance of the ADI for all population groups at mean and high level of exposure. For this scenario, 
the main contributors were flavoured fermented milk products (up to 77 %) and fine bakery wares (up 
to 67 %). 
Refined exposure estimates on tier 3 in the previous opinion were based on the data provided by food 
industry assuming that β-apo-8‟-carotenal is being used in the entire food category while usage levels 
were in some cases provided for specific food items not representing the entire category. However, 
only  few  categories  were  taken  into  account  for  these  exposure  calculations.  New  data  provided 
indicated that β-apo-8‟-carotenal is being used in a broader range of food categories. This has been 
taken into account in the new exposure calculation leading to exposure estimates being in a similar 
range as compared to those from the previous opinion.  
Usage levels provided by industry were based on the data reported from member companies and data 
based on analysis on a relatively small number of samples. According to the data provider, the samples 
for chemical analysis were selected based on the colour of the product, the primary presence of β-apo-
8‟-carotenal as the only colour added to foods placed on the European market between 2008 and 2013 
and in order to obtain as many products of different types as possible. From these data, the highest 
reported level was used for the exposure estimates in scenario UL1, although for the category “other 
confectionery with added sugar” only one product from one supplier contained β-apo-8‟-carotenal at 
the level reported. In addition, the report on usage levels made available to the Panel pointed out, that 
β-apo-8‟-carotenal is a niche colour for very specific applications (e.g. adjusting the shade of orange 
colour resulting from the use of other colours, mainly beta-carotene). The report also provided some 
evidence that β-apo-8‟-carotenal is only used in 0.8 % of all products in the category “flavoured drinks 
with sugar” or “flavoured drinks with sweeteners”. Taking all this information and the limitations 
indicated in the exposure section into account, the Panel considers it likely that exposure to β-apo-8‟-
carotenal is lower than the exposure estimates provided in scenario UL1.  
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CONCLUSIONS 
The Panel concluded that based on the NOAEL of 30 mg/kg bw/day from the 13-week study in rats, in 
which tubular cell injury was observed at 100 mg/kg bw/day, and using an uncertainty factor of 100, 
an  ADI  for  β-apo-8‟-carotenal  of  0.3  mg/kg  bw/day  was  established.  The  Panel  considered  an 
uncertainty factor of 100 as sufficient, not needing an extra adjusting factor due to the pivotal study 
being a sub-chronic study (and not a chronic study), given the fact that tubular injury was not observed 
in the 2-year study at 40 mg/kg bw/day, the single dose tested. 
Scenarios used for the exposure assessment based on the MPLs or use levels in reported categories 
combined with the MPLs for other categories led to an exceedance of the ADI up to 10-20 fold in all 
population groups, both at mean and high level exposure.  
However, a further refined exposure scenario was based only on the limited number of categories 
where industry reported use levels and analytical data. Exposure estimates using this scenario were 
below the ADI at the mean level for all population groups. At high level of exposure, the ADI was 
exceeded for toddlers and children, and the exposure for adolescents was at about the ADI. The Panel 
considered  that  this  high  level  exposure  estimate  was  still  conservative  and  concluded  that  these 
exceedances are unlikely to occur. The Panel concluded that using data provided by the food industry, 
which are based only on a limited number of regulated categories, the reported uses and use levels of 
β-apo-8‟-carotenal (E 160e) would not be of safety concern.  
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ABBREVIATIONS 
ADI  acceptable daily intake  
ANS  Scientific Panel on Food Additives and Nutrient Sources added to Food 
EC  European Commission 
EFSA  European Food Safety Authority 
EU   European Union  
LOAEL  lowest observed adverse effect level 
MNH  multinucleated hepatocytes  
MPL  maximum permitted level 
NDNS  UK National Dietary and Nutrition Survey  
NOAEL  no observed adverse effect level  
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APPENDICES 
Appendix A.   Summary of levels of β-apo-8’-carotenal (E 160e) provided by industry (mg/kg or mg/l)  
FCS 
category 
No 
Food categories  MPL  Restrictions/exceptions 
Levels reported  
Information 
provided by  Typical/ 
mean  Max 
1.4  Flavoured  fermented  milk  products  including  heat-
treated products  150    –  –   
1.6.3  Other creams  150  only flavoured creams  –  –   
1.7.1  Unripened  cheese  excluding  products  falling  in 
category 16  150  only flavoured unripened cheese  –  0.4
(e)  NATCOL 
1.7.3  Edible cheese rind  QS    –  –   
1.7.5  Processed cheese  100
(a)  only flavoured processed cheese  –  –   
1.7.6  Cheese  products  (excluding  products  falling  in 
category 16)  100  only flavoured unripened products  –  –   
3  Edible ices  150    –  –   
4.2.4.1  Fruit and vegetable preparations excluding compote  200  only mostarda di frutta  –  –   
5.2.  Other  confectionery  including  breath  freshening 
microsweets 
300  except candied fruit and vegetables 
20
(e)  104
(e) 
NATCOL
(f) 
2.5
(e)  2.9
(e) 
200  only candied fruit and vegetables  2  2  FDE 
5.3.  Chewing gum  300   
14  25  ICGA 
12.5  15  NATCOL 
5.4.  Decorations, coatings and fillings, except fruit based 
fillings covered by category 4.2.4  500  only decorations, coatings and sauces, 
except fillings  1-3  3  FDE 
5.4.  Decorations, coatings and fillings, except fruit based 
fillings covered by category 4.2.4  300  only fillings  11  11  FDE 
6.6  Batters  500  only batters for coating  –  –   
7.2.  Fine bakery wares  200    1.8
(e)  3.5
(e)  NATCOL 
8.2.3  Casings and coatings and decorations for meat   500  only decorations and coatings except 
edible external coating of pasturmas  –  –   
8.2.3  Casings and coatings and decorations for meat  QS  only edible casings  –  –   
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Appendix A :  Summary of levels of β-apo-8’-carotenal (E 160e) provided by industry (mg/kg or mg/l) continued 
FCS 
category 
No 
Food categories  MPL  Restrictions/exceptions 
Levels reported  
Information 
provided by  Typical/ 
mean  Max 
9.2.  Processed  fish  and  fishery  products  including 
molluscs and crustaceans 
100
(b)  only fish paste and crustacean paste 
12.5  15  NATCOL 
500  only surimi and similar products and salmon 
substitutes 
250
(c)  only precooked crustacean 
100
(d)  only smoked fish 
9.3  Fish roe  300  except Sturgeons' eggs (Caviar)  –  –   
12.2.2  Seasonings and condiments   500  only seasonings, for example curry powder, 
tandoori  50  50  FDE
(f) 
12.4  Mustard  300    –  –   
12.5  Soups and broths  50   
8.5  14  NATCOL 
5  10  FDE 
12.6  Sauces  500  including pickles, relishes, chutney and 
piccalilli; excluding tomato-based sauces  50  50  FDE
(f) 
12.9  Protein  products,  excluding  products  covered  in 
category 1.8  100  only meat and fish analogues based on 
vegetable proteins  –  –   
13.2 
Dietary foods for special medical purposes defined in 
Directive 1999/21/EC (excluding products from food 
category 13.1.5) 
50    –  –   
13.3 
Dietary  foods  for  weight  control  diets  intended  to 
replace total daily food intake or an individual meal 
(the whole or part of the total daily diet) 
50    –  –   
14.1.4  Flavoured drinks  100  excluding chocolate milk and malt products 
1-2  1-7  FDE
(f) 
3.4
(e)  9.6
(e)  NATCOL
(f) 
14.2.3  Cider and perry  200  excluding cidre bouché  –  –   
14.2.4  Fruit wine and made wine   200    –  –   
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Appendix A :  Summary of levels of β-apo-8’-carotenal (E 160e) provided by industry (mg/kg or mg/l) continued 
FCS 
category 
No 
Food categories  MPL  Restrictions/exceptions 
Levels reported  
Information 
provided by  Typical/ 
mean  Max 
14.2.6  Spirit  drinks  as  defined  in  Regulation  (EC)  No 
110/2008  200 
except: spirit drinks as defined in article 5(1) 
and  sales  denominations  listed  in  Annex  II, 
paragraphs  1-14  of  Regulation  (EC)  No 
110/2008 and spirits (preceded by the name 
of  the  fruit)  obtained  by  maceration  and 
distillation,  London  Gin,  Sambuca, 
Maraschino,  Marrasquino  or  Maraskino  and 
Mistrà 
–  –   
14.2.7.1  Aromatised wines   200  except americano, bitter vino  –  –   
14.2.7.2  Aromatised wine-based drinks  200  except bitter soda, sangria, claria, zurra  –  –   
14.2.7.3  Aromatised wine-product cocktails   200    –  –   
14.2.8 
Other  alcoholic  drinks  including  mixtures  of 
alcoholic drinks with non-alcoholic drinks and spirits 
with less than 15 % of alcohol 
200  only alcoholic drinks with less than 15 % of 
alcohol  –  –   
15.1  Potato-, cereal-, flour- or starch-based snacks  100  excluding extruded or expanded savoury 
snack products  –  –   
15.1  Potato-, cereal-, flour- or starch-based snacks  200  only extruded or expanded savoury snack 
products  –  –   
15.2  Processed nuts  100  only savoury-coated nuts  –  –   
16  Desserts excluding products covered in categories 1, 
3 and 4  150    6.9
(e)  10.8
(e)  NATCOL 
17.1 
Food supplements supplied in a solid form including 
capsules  and  tablets  and  similar  forms,  excluding 
chewable forms  
300    8.5-260  16-260  AESGP
(f) 
17.2  Food supplements supplied in a liquid form  100    –  –   
17.3  Food  supplements  supplied  in  a  syrup-type  or 
chewable form  300  only solid food supplements  –  –   
17.3  Food  supplements  supplied  in  a  syrup-type  or 
chewable form  100  only liquid food supplements  –  –   
(a):  Maximum individually or for the combination of E 100, E 102, E 104, E 110, E 120, E 122, E 124, E 160e and E 161b 
(b):  Maximum individually or for the combination of E 102, E 104, E 110, E 120, E 122, E 124, E 142, E 151, E 160e and E 161b 
(c):  Maximum individually or for the combination of E 102, E 110, E 120, E 122, E 124, E 129, E 142, E 151, E 160e and E 161b  
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(d):  Maximum individually or for the combination of E 102, E 110, E 120, E 124, E 151 and E 160e 
(e):  Measured β-apo-8‟-carotenal content of foods and beverages reported by industry 
(f):   Value was reported at a lower level of detail, but was assigned to the higher food categorization level for the exposure assessment. 
  QS,  quantum satis; – use levels were not reported by industry 
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Appendix B.   Summary of reported levels of β-apo-8’-carotenal (E 160e) used in the exposure assessment (mg/kg or mg/l) 
FCS 
category 
No 
Food categories 
Scenarios 
Scenario 1  Scenario 2 
1.4  Flavoured fermented milk products including heat-treated products  0  150 
1.6.3  Other creams  0  150 
1.7.1  Unripened cheese excluding products falling in category 16  0.4
(a)  150 
1.7.5  Processed cheese  0  100 
3  Edible ices  0  150 
5.2.  Other confectionery including breath freshening microsweets  104
(a)  300 
5.3.  Chewing gum  25  25 
7.2.  Fine bakery wares  3.5
(a)  200 
9.2.  Processed fish and fishery products including molluscs and crustaceans  15  15 
9.3  Fish roe  0  300 
12.2.2  Seasonings and condiments   50  50 
12.4  Mustard  0  300 
12.5  Soups and broths  14  14 
12.6  Sauces  50  50 
12.9  Protein products, excluding products covered in category 1.8  0  100 
13.2  Dietary foods for special medical purposes defined in Directive 1999/21/EC (excluding products from 
food category 13.1.5)  0  50 
13.3  Dietary foods for weight control diets intended to replace total daily food intake or an individual meal 
(the whole or part of the total daily diet)  0  50 
14.1.4  Flavoured drinks  9.6
(a), (b)  7
(b) 
14.2.3  Cider and perry 
0  200
(c) 
14.2.6  Spirit drinks as defined in Regulation (EC) No 110/2008 
14.2.7.1  Aromatised wines  
14.2.7.2  Aromatised wine-based drinks 
14.2.7.3  Aromatised wine-product cocktails  
14.2.8  Other alcoholic drinks including mixtures of alcoholic drinks with non-alcoholic drinks and spirits 
with less than 15 % of alcohol 
15.1  Potato-, cereal-, flour- or starch-based snacks  0  200 
15.2  Processed nuts  0  100 
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Appendix B :  Summary of reported levels of β-apo-8’-carotenal (E 160e) used in the exposure assessment (mg/kg or mg/l) continued. 
FCS 
category 
No 
Food categories 
Scenarios 
Scenario 1  Scenario 2 
16  Desserts excluding products covered in categories 1, 3 and 4  10.8
(a)  150 
17.1  Food supplements supplied in a solid form including capsules and tablets and similar forms, excluding 
chewable forms  
260  260  17.2  Food supplements supplied in a liquid form 
17.3  Food supplements supplied in a syrup-type or chewable form 
17.3  Food supplements supplied in a syrup-type or chewable form 
(a): Measured β-apo-8‟-carotenal content of foods and beverages reported by industry 
(b): excluding cola beverages 
(c): excluding beers and wines  
                               Reconsideration of the ADI and refined exposure assessment of β-apo-8′-carotenal (E 160e) 
 
 
EFSA Journal 2014;12(1):3492  29 
 
Appendix C.   Summary of total estimated exposure to β-apo-8’-carotenal (E 160e) using MPLs and use levels per age class and survey: mean and 
high level (mg/kg bw/day)
(a) 
    MPL  UL1  UL2 
Age class  Survey  Mean  High level  Mean  High level  Mean  High level 
Toddlers  DIPP  1.0  3.2  0.0  0.1  0.9  3.0 
   DONALD_2006_2008  1.3  3.4  0.0  0.2  0.9  2.4 
   enKid  1.6  n/a  0.0  n/a  1.6  n/a 
   INRAN_SCAI_2005_06  1.2  n/a  0.0  n/a  0.9  n/a 
   NUTRICHILD  1.2  2.8  0.1  0.2  0.9  2.4 
   Regional_Flanders  3.9  n/a  0.3  n/a  2.2  n/a 
   VCP_kids  3.4  7.4  0.2  0.5  2.5  6.1 
Children  Danish_Dietary_Survey  1.6  2.9  0.1  0.3  0.7  1.4 
   DIPP  1.3  3.0  0.1  0.3  1.0  2.3 
   DONALD_2006_2008  1.9  4.2  0.1  0.3  1.1  2.2 
   EFSA_TEST  1.5  3.5  0.1  0.3  0.8  2.0 
   enKid  1.6  3.9  0.1  0.3  1.1  2.7 
   INCA2  1.9  3.5  0.1  0.2  1.3  2.5 
   INRAN_SCAI_2005_06  1.0  2.4  0.0  0.1  0.8  1.8 
   NFA  3.0  5.9  0.2  0.5  1.5  3.2 
   NUT_INK05  1.6  3.3  0.1  0.2  1.0  2.2 
   NUTRICHILD  1.5  3.5  0.1  0.2  1.0  2.4 
   Regional_Crete  1.1  2.4  0.0  0.2  0.9  2.0 
   Regional_Flanders  3.3  6.7  0.2  0.4  1.9  4.5 
   SISP04  1.9  4.3  0.1  0.3  1.2  2.6 
   STRIP  2.7  4.6  0.2  0.5  1.3  2.4 
   VCP_kids  3.1  6.2  0.2  0.4  2.2  5.1 
Adolescents  AESAN_FIAB  0.5  1.0  0.0  0.1  0.4  0.9 
   Childhealth  0.5  1.3  0.0  0.1  0.2  0.5 
   Danish_Dietary_Survey  1.1  2.5  0.1  0.3  0.4  1.0 
   Diet_National_2004  1.1  2.5  0.1  0.2  0.5  1.1 
   EFSA_TEST  1.0  2.5  0.1  0.2  0.5  1.4 
   enKid  1.0  2.3  0.1  0.2  0.6  1.4  
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   INCA2  0.9  1.9  0.0  0.1  0.6  1.3 
   INRAN_SCAI_2005_06  0.6  1.5  0.0  0.1  0.4  1.0 
   National_Nutrition_Survey_II  1.0  2.4  0.1  0.2  0.4  1.3 
   NFA  1.7  3.4  0.1  0.3  0.8  1.8 
   NUT_INK05  0.8  1.9  0.1  0.1  0.5  1.2 
   SISP04  1.4  3.3  0.1  0.3  0.8  1.8 
Adults  AESAN  0.4  1.1  0.0  0.1  0.3  0.8 
   AESAN_FIAB  0.3  0.9  0.0  0.0  0.3  0.7 
   Danish_Dietary_Survey  0.5  1.3  0.0  0.1  0.2  0.5 
   Diet_National_2004  0.8  2.1  0.1  0.2  0.4  1.0 
   DNFCS_2003  1.1  2.4  0.1  0.2  0.5  1.2 
   EFSA_TEST  0.6  1.3  0.1  0.1  0.3  0.8 
   FINDIET_2007  0.4  1.1  0.0  0.1  0.3  0.9 
   INCA2  0.6  1.3  0.0  0.1  0.4  0.9 
   INRAN_SCAI_2005_06  0.3  0.8  0.0  0.0  0.3  0.6 
   National_Nutrition_Survey_II  0.7  1.8  0.1  0.2  0.4  1.0 
   National_Repr_Surv  0.3  0.9  0.0  0.1  0.2  0.4 
   NDNS  0.7  1.5  0.0  0.1  0.4  0.8 
   NSIFCS  0.5  1.2  0.0  0.1  0.3  0.7 
   Riksmaten_1997_98  0.7  1.7  0.1  0.1  0.3  0.7 
   SISP04  0.6  1.5  0.0  0.1  0.4  0.9 
The elderly  Danish_Dietary_Survey  0.3  0.7  0.0  0.1  0.2  0.5 
   Diet_National_2004  0.6  1.5  0.1  0.1  0.3  0.9 
   FINDIET_2007  0.2  0.6  0.0  0.0  0.1  0.5 
   INCA2  0.4  0.9  0.0  0.0  0.3  0.7 
   INRAN_SCAI_2005_06  0.2  0.6  0.0  0.0  0.2  0.5 
   National_Nutrition_Survey_II  0.6  1.3  0.0  0.1  0.4  0.9 
   National_Repr_Surv  0.3  0.8  0.0  0.0  0.2  0.4 
(a):  The different methodologies of European dietary surveys included in the EFSA Comprehensive Database are fully described in the Guidance on the use of the EFSA Comprehensive 
European Food Consumption Database in Exposure Assessment (EFSA, 2011a). A summary is available on p. 11, Table 1, of the guidance. 